VT
NVO

Vise Technologies’s Novo Nordisk NVO Stock Holding History

Vise Technologies’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Buy
55,435
+20,221
+57% +$869K 0.03% 448
2026
Q1 		$1.79M Hold
35,214
– – 0.04% 404
2025
Q4 		$1.79M Buy
35,214
+8,485
+32% +$434K 0.04% 405
2025
Q3 		$1.48M Sell
26,729
-403
-1% -$23.6K 0.06% 325
2025
Q2 		$1.87M Buy
+27,132
New +$1.85M 0.08% 278
2024
Q4 		$1.76M Buy
20,443
+862
+4% +$93.2K 0.15% 148
2024
Q3 		$2.33M Sell
19,581
-652
-3% -$87K 0.3% 74
2024
Q2 		$2.89M Buy
20,233
+519
+3% +$68.8K 0.51% 42
2024
Q1 		$2.53M Sell
19,714
-641
-3% -$76.3K 0.5% 45
2023
Q4 		$2.11M Buy
20,355
+927
+5% +$91.7K 0.45% 56
2023
Q3 		$1.77M Sell
19,428
-518
-3% -$45.6K 0.43% 54
2023
Q2 		$1.61M Buy
19,946
+1,104
+6% +$90.2K 0.39% 61
2023
Q1 		$1.5M Buy
18,842
+1,090
+6% +$77.3K 0.4% 59
2022
Q4 		$1.2M Buy
17,752
+2,044
+13% +$120K 0.38% 58
2022
Q3 		$782K Buy
15,708
+910
+6% +$48.7K 0.29% 73
2022
Q2 		$824K Buy
14,798
+7,418
+101% +$412K 0.32% 73
2022
Q1 		$410K Buy
+7,380
New +$379K 0.15% 139

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Vise Technologies's NVO Position: Q2 2026 in Review

Vise Technologies increased its Novo Nordisk (NVO) stake by 57% in Q2 2026, buying an estimated $869K and bringing the position to 55,435 shares worth $2.66M. The position accounts for 0.03% of the portfolio, ranked #448.

Vise Technologies first reported a position in NVO in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.89M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Vise Technologies held 55,435 shares of Novo Nordisk worth $2.66M as of Q2 2026.
  • Vise Technologies bought 20,221 Novo Nordisk shares in Q2 2026, an estimated $869K.
  • Novo Nordisk made up 0.03% of Vise Technologies's portfolio in Q2 2026, its #448 holding.
  • Vise Technologies first reported a position in Novo Nordisk in Q1 2022 and has held it in 17 quarters since.
  • Vise Technologies's Novo Nordisk position peaked at $2.89M in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.